{
    "pmcid": "11750110",
    "qa_pairs": {
        "How can ESM's predictive capabilities be adapted for SARS-CoV-2 nanobody design?": [
            "By predicting nanobody performance against emerging variants and refining designs based on feedback.",
            "By identifying new viral strains through genetic analysis.",
            "By determining the most effective dosage for nanobody administration.",
            "By analyzing the geographical spread of the virus to target specific regions."
        ],
        "How does the Epidemic Spreading Model (ESM) relate to SARS-CoV-2 nanobody design?": [
            "It models dynamic interactions, considers immune responses, and optimizes parameters like binding affinities.",
            "It focuses on genetic mutations of the virus to design effective nanobodies.",
            "It uses environmental data to predict virus spread and nanobody efficacy.",
            "It analyzes patient demographics to tailor nanobody treatments."
        ],
        "What aspect of the ESM's complexity is paralleled in nanobody design?": [
            "Detailed parameterization such as binding kinetics and stability across viral variants.",
            "The use of genetic sequencing to identify viral mutations.",
            "The incorporation of environmental factors affecting virus transmission.",
            "The focus on patient-specific treatment plans."
        ],
        "What is the primary focus of the paper 'Connectome-based biophysical models of pathological protein spreading in neurodegenerative diseases'?": [
            "Simulating the spread of pathological proteins in neurodegenerative diseases using computational models.",
            "Developing new therapeutic drugs for neurodegenerative diseases.",
            "Analyzing genetic mutations responsible for neurodegenerative diseases.",
            "Studying the environmental factors contributing to neurodegenerative diseases."
        ],
        "Which model considers both endogenous and exogenous infections along with the brain's immune response?": [
            "Epidemic Spreading Model (ESM)",
            "Network Diffusion Model (NDM)",
            "Agent-based Susceptible-Infectious-Removed (SIR) model",
            "Prion-like Transmission Model"
        ]
    }
}